HNF1A Gene MODY Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين HNF1A لمرض السكري الشبابي النوع الثالث (MODY 3) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

ملخص تنفيذي: اختبار HNF1A لتشخيص النوع الثالث من السكري الشبابي (MODY 3) بواسطة التسلسل الجيني فائق الدقة (NGS) بدقة تشخيصية تبلغ 99.9% وتحت اعتماد ISO 9001:2015 وترخيص هيئة الصحة بدبي.

✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
✓Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
✓Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation by DHA-Licensed Specialists.
✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

The HNF1A gene MODY Type 3 NGS test detects pathogenic variants causing maturity‑onset diabetes of the young, a monogenic form of diabetes that often mimics Type 1 or Type 2 diabetes but requires distinct management. This single‑gene analysis empowers clinicians to confirm a molecular diagnosis, guide sulfonylurea therapy, and screen at‑risk relatives with unmatched precision.

Feature	Our Test (Premium MODY3 NGS)	Closest Alternative (Generic Diabetes Panel)
Technology	Next‑Generation Sequencing (NGS) with full gene coverage & copy‑number analysis	PCR‑based targeted genotyping (limited to few SNPs)
Sensitivity	99.9% analytical sensitivity for single nucleotide variants & small indels	Variable; misses up to 30% of causal mutations
Turnaround Time	3–4 weeks with optional STAT reporting	4–6 weeks
Clinical Report	Interpreted by DHA‑licensed diabetologist & board‑certified geneticist	Automated bioinformatics report without specialist sign‑off

Physician Insight & Safety Protocol

“A positive HNF1A mutation result not only confirms MODY but also opens the door to sulfonylurea therapy, often replacing insulin. Yet, every result must be correlated with the full clinical picture; a negative result does not exclude other genetic or acquired forms of diabetes. Please discuss every report with your managing physician.”
— Dr. PRABHAKAR REDDY, DHA License 61713011

! Medication Warning

Do not discontinue prescribed medication without consulting your doctor. This genetic test does not provide immediate treatment guidance. Any change in diabetes management must be supervised by your endocrinologist.

⚕️ Safety Exclusion Criteria & Emergency Red Flags

Exclusion: Subjects unable to give valid informed consent (unless authorized legal guardian provides consent under UAE law).
Exclusion: Acute metabolic decompensation (e.g., diabetic ketoacidosis) requiring immediate hospitalization; genetic testing can be done after stabilization.
ER Red Flag: If you experience severe hyperglycemia (blood glucose >250 mg/dL) with confusion, vomiting, or fruity breath odor, proceed to the nearest emergency department before test scheduling.
Pediatric testing of minors strictly adheres to UAE Child Protection Law (CDS Law 2026) with mandatory guardian presence and genetic counseling.

Patient FAQ & Clinical Guidance

1. What is the HNF1A MODY3 test, and how is it performed?

The test uses next‑generation sequencing to analyze all coding regions of the HNF1A gene from a blood sample or a single drop of blood on an FTA card. A painless venous blood draw (or finger‑prick for card) is collected by a DHA‑licensed phlebotomist during an at‑home visit, and the specimen is transported in a cold‑chain to our ISO 9001:2015 certified laboratory for sequencing and interpretation.

2. Who should consider this genetic?

Individuals with diabetes diagnosed before age 25, a strong family history of diabetes across generations, absence of pancreatic autoantibodies, or those who respond unusually well to sulfonylureas should consider HNF1A MODY testing to differentiate monogenic from type 1/2 diabetes.

3. ماذا تعني نتيجة الاختبار؟ وماذا يحدث بعد الحصول عليها؟

تكشف تقنية NGS عن وجود طفرات مرضية في جين HNF1A، وعند تأكيدها، يمكن لطبيب الغدد الصماء وصف علاج السلفونيل يوريا بدلاً من الأنسولين، مع متابعة دورية لنسبة HbA1c. تستلم تقريرًا شاملاً باللغة الإنجليزية يضم التفسير السريري المُعتمد من هيئة الصحة بدبي، وجلسة افتراضية عبر الهاتف مع أخصائي السكري لمناقشة الخطوات التالية.

Regulatory Compliance: This service fully adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic testing, UAE PDPL for data privacy, and the latest 2026 DHA genetic testing standards. Our laboratory holds ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139) and operates under MOHAP Facility License 9834453.

دعم ثنائي اللغة متاح